[Skip to Content]
[Skip to Content Landing]
Views 289
Citations 0
Editor's Correspondence
April 8, 2013

DMAA as a Dietary Ingredient—Reply

Author Affiliations

Author Affiliation: Department of Medicine, Cambridge Health Alliance and Harvard Medical School, Cambridge, Massachusetts.

JAMA Intern Med. 2013;173(7):594-595. doi:10.1001/jamainternmed.2013.3776

In reply

Rodricks and Lumpkin argue that 1,3-dimethylamylamine (DMAA) does not possess amphetamine-like effects, is found in geranium, and has been documented to be safe. These are all inaccurate characterizations of the literature.

DMAA is a pharmaceutical patented by Eli Lilly & Co to possess the desirable properties of both ephedrine and amphetamine. An indirect sympathomimetic amine, DMAA has both vasoconstrictive properties and cardiovascular effects.

First Page Preview View Large
First page PDF preview
First page PDF preview
×